Meta-analysis of the safety of voriconazole in definitive, empirical, and prophylactic therapies for invasive fungal infections
Abstract Background Voriconazole has been used in the treatment and prophylaxis of invasive fungal infections (IFIs) while its wide use was limited by some frequent adverse events, especially neurotoxicity, hepatotoxicity and even renal disruption. The aim of this study was to comprehensively compar...
Main Authors: | Yuanming Xing, Lu Chen, Yan Feng, Yan Zhou, Yajing Zhai, Jun Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-12-01
|
Series: | BMC Infectious Diseases |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12879-017-2913-8 |
Similar Items
-
Natamycin versus voriconazole for fungal keratitis
by: José Retamal, et al.
Published: (2018-12-01) -
Oral voriconazole monotherapy for fungal keratitis: efficacy, safety, and factors associated with outcomes
by: Youran Cai, et al.
Published: (2023-05-01) -
Is Halving Maintenance of Voriconazole Safe and Efficient in Patients Suffering from Invasive Fungal Infections with Serious Hepatic Dysfunction?
by: Cai X, et al.
Published: (2023-01-01) -
Inflammation Affects Liver Function and the Metabolism of Voriconazole to Voriconazole-N-Oxide in Adult and Elderly Patients
by: Zaiming Liang, et al.
Published: (2022-04-01) -
The Use of Voriconazole as Primary Prophylaxis for Invasive Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation: A Single Center’s Experience
by: Ali Atoui, et al.
Published: (2021-10-01)